Clinical studies recruiting near Omsk

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Lipoprotein(a) Levels in Patients With Atherosclerotic Cardiovascular Diseases in Russia
Phase N/A · Novartis Investigative Site · Novartis Pharmaceuticals · NCT06858332 Aggressive Disease Treatment Patterns and CtDNA HRR evaluatiON in High-volume metastatiC hORmone-sensitive Prostate Canc
Phase N/A · Research Site · AstraZeneca · NCT07052578 A Study to Investigate the Effects of Zibotentan/Dapagliflozin Combination Compared to Dapagliflozin Alone in Adult Part
Phase 2 · Research Site · AstraZeneca · NCT06942910 A Safety and Efficacy Study of Bevacizumab, Paclitaxel, Carboplatin Compared to Avastin® in Non-Small Cell Lung Cancer
Phase 3 · Omsk clinical oncologic dispensary · Mabscale, LLC · NCT05654454 A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular
Phase 1 · Budgetary Healthcare Institution of Omsk region "Clinical On · Pfizer · NCT03460977 A Comparative Study of Pharmacokinetics, Safety, and Immunogenicity of RPH-030 and Vectibix® in Patients With Metastatic
Phase 1 · Omsk Region Budgetary Healthcare Institution "Clinical Oncol · R-Pharm · NCT07543744 A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
Phase 2 · Site RU70005 · Astellas Pharma Global Development, Inc. · NCT02960022 Clinical and demOgRaphic Features of Patients With Uncontrolled Severe Asthma in Russia (CORSAR)
Phase N/A · Research Site · AstraZeneca · NCT06472310 TReatment Approaches and bIomarkers preValence in bladdEr Cancer in RuSsian Federation
Phase N/A · Research Site · AstraZeneca · NCT07038928 BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)
Phase 1/Phase 2 · Byudzhetnoye Uchrezhdeniye Zdravookhraneniya Omskoy Oblasti · BioInvent International AB · NCT04752826 BCD-236 in Combination With Chemotherapy in Patients With Relapsed and/or Metastatic Triple Negative Breast Cancer
Phase 2 · Budget Healthcare Institution of the Omsk region "Clinical O · Biocad · NCT07108309 Clinical Trial of the Efficacy and Safety of Raphamin in the Treatment of ARVI in Children Aged 3-12 Years
Phase 3 · Omsk State Medical University/Department of Hospital Pediatr · Materia Medica Holding · NCT06715891 Clinical& Demographic Profiles of patIents With unControllEd Asthma in Russia: Multi-center oBsErvational ReGistry Study
Phase N/A · Research Site · AstraZeneca · NCT06521229 Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonanc
Phase 4 · BHI of Omsk region "Clinical Oncology Dispensary" · Guerbet · NCT04373564 Efficacy and Safety of Rengalin in the Treatment of ARVI Cough in Children
Phase 3 · Omsk State Medical University/Department of Hospital Pediatr · Materia Medica Holding · NCT07171099 A Study of the Efficacy and Safety of BCD-248 in Combination With Daratumumab in Patients With Relapsed or Refractory Mu
Phase 3 · BHI of the Omsk region "Clinical Oncological Dispensary" · Biocad · NCT07742215

Look up another city

Look up another condition